GainersToday.com
GainersToday.com, Tracking Stock Market Picks
Enter Symbol:
 
Resmed Inc. (RMD) [hlAlert]

Rating:
Neutral RMD
up 100.09 %

Resmed Inc. (RMD) downgraded to Neutral by JP Morgan

Posted on: Friday,  Feb 28, 2014  8:25 AM ET by JP Morgan

JP Morgan rated Neutral Resmed Inc. (NYSE: RMD) on 02/28/2014. Previously JP Morgan rated Overweight Resmed Inc. (NYSE: RMD) on 08/10/2009.,
when the stock price was $22.00. Since then, Resmed Inc. has gained 100.09% as of 02/28/2014's recent price of $44.02.
If you would have followed the previous JP Morgan's recommendation on RMD, you would have gained 100.09% of your investment in 1663 days.

ResMed Inc. is a holding company. Through its subsidiaries, the Company develops, manufactures and distributes medical equipment for treating, diagnosing and managing sleep-disordered breathing (SDB) and other respiratory disorders, including obstructive sleep apnea (OSA). It has developed nasal continuous positive airway pressure (CPAP) as a non-invasive treatment for OSA. CPAP systems deliver pressurized air, typically through a nasal mask, to prevent collapse of the upper airway during sleep. The Company has developed a number of products for SDB and other respiratory disorders, including airflow generators, diagnostic products, mask systems, headgear and other accessories. ResMed Inc. sells its products in over 70 countries through a combination of wholly owned subsidiaries and independent distributors to sleep clinics, home healthcare dealers and third-party payers. On April 30, 2009, it acquired Respicure Medsys PVT.LTD. In October 2009, ResMed Inc. acquired Laboratoires Narval.

JPMorgan is a leading financial services firm with one of the largest client franchises in the world. We partner with our clients to offer the most complete and innovative solutions in the industry to help them achieve their goals. For more than 200 years, we have taken a long-term approach to our clients and to the way we conduct business. Our firm has grown considerably in scale and scope, but our commitment to our core principle of doing "only first-class business... in a first-class way" has never been stronger.
Stock Market Advice
Date/Time (ET)SymbolRatingTermPrice (*)Target
2/28/2014 8:25 AM Hold
None
44.02
as of 10/17/2014
1 Week   
1 Month   
3 Months   
1 YTD down  -6.49 %
Previous Recommendations
Date/Time (ET)SymbolRatingTermPrice (*)Target
8/10/2009 8:25 AM Buy
None
22.00
2/9/2009 8:25 AM Hold
None
20.54

(*) Stock Price at the time of the recommendation.
RSS Feed | |  Facebook |  Twitter |  Google Plus
Home | Terms of Use | Advertise | FAQ | Support Page | Contact Us | About Us | Privacy Policy